Although treating anemia of chronic kidney disease by erythropoiesis-stimulating agents (ESA) may improve survival, most studies have examined associations between baseline hemoglobin values and survival and ignored variations in clinical and laboratory measures over time. It is not clear whether lo...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!